UAB Digital Repository of Documents 2 records found  Search took 0.01 seconds. 
8 p, 1.6 MB Unplanned admissions for patients with myeloma in the UK : Low frequency but high costs / Kolovos, Spyros (University of Oxford. Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences) ; Nador, Guido (Oxford University Hospitals NHS Trust) ; Kishore, Bhuvan (Heart of England NHS Foundation Trust) ; Streetly, Matthew (King's College London) ; Rabin, Neil K. (Department of Haematology, University College London Hospitals NHS Foundation Trust) ; Chantry, Andrew D (Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital) ; Yong, Kwee (UCL Cancer Institute (Londres, Regne Unit)) ; Ashcroft, John (Department of Haematology, Mid Yorkshire NHS Trust) ; Bowcock, Stella (King's College Hospital NHS Foundation Trust) ; Drayson, Mark T. (Institute of Immunology and Immunotherapy, University of Birmingham) ; Ramasamy, Karthik (Oxford University Hospitals NHS Trust) ; Prieto-Alhambra, Daniel (Universitat Autònoma de Barcelona) ; Cooper, Cyrus (NIHR Oxford Biomedical Research Centre, University of Oxford) ; Javaid, M. Kassim (Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford) ; Pinedo-Villanueva, Rafael (Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford)
Multiple myeloma (MM) is associated with high healthcare resource utilisation and increasing hospitalisation rates. The aim of this study was to characterise the hospital use by patients with MM in the English National Health Service (NHS). [...]
2019 - 10.1016/j.jbo.2019.100243
Journal of Bone Oncology, Vol. 17 (august 2019)  
12 p, 675.8 KB Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer : Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG / Hadji, Peyman (Krankenhaus Nordwest) ; Aapro, Matti S. (Genolier Cancer Center, Switzerland) ; Body, Jean-Jacques (CHU Brugmann, Université Libre de Bruxelles, Belgium) ; Gnant, Michael (Medical University of Vienna, Austria) ; Brandi, Maria Luisa (University of Florence, Italy) ; Reginster, Jean Yves (University of Liège, Belgium) ; Zillikens, M. Carola (Erasmus MC, Rotterdam, Netherlands) ; Glüer, Claus-C. (Univeristy of Kiel, Germany) ; de Villiers, Tobie (University of Stellenbosch, Cape Town, South Africa) ; Baber, Rod (University of Sydney, Australia) ; Roodman, G. David (Indiana University School of Medicine, USA) ; Cooper, Cyrus (University of Southampton, UK) ; Langdahl, Bente (Aarhus University, Denmark) ; Palacios, Santiago (Instituto Palacios Madrid, Spain) ; Kanis, John (Catholic University of Australia, Melbourne, Australia and University of Sheffield, UK) ; Al-Daghri, Nasser (University of Riyadh, Saudi Arabia) ; Nogués Solán, Xavier (Universitat Autònoma de Barcelona) ; Eriksen, Erik Fink (University of Oslo, Norway) ; Kurth, Andreas (Klinikum Birkenwerder, Germany) ; Rizzoli, Rene (Geneva University, Switzerland) ; Coleman, Robert E. (University of Sheffield, UK)
Several guidelines have been reported for bone-directed treatment in women with early breast cancer (EBC) for averting fractures, particularly during aromatase inhibitor (AI) therapy. Recently, a number of studies on additional fracture related risk factors, new treatment options as well as real world studies demonstrating a much higher fracture rate than suggested by randomized clinical controlled trials (RCTs). [...]
2017 - 10.1016/j.jbo.2017.03.001
Journal of Bone Oncology, Vol. 7 (June 2017) , p. 1-12  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.